Philippines Healthcare and Pharmaceuticals Sector Report 2016/2017

  • ID: 4330152
  • Report
  • Region: Philippines
  • 65 pages
  • EMIS, A Euromoney Institutional Investor Company
1 of 4

The Philippines healthcare and pharmaceuticals sector has grown gradually in past years due to the country's population and economic growth. Recently, sector growth has accelerated due to policy measures to increase the healthcare budget which have led to an increase in the amount of funds available for healthcare facilities upgrading and for financing healthcare spending by the poor.

There is, however, persistent migration of qualified medical workers from the provinces to Metro Manila, or outside the Philippines, which limits sector potential. Pharmaceuticals prices in the Philippines remain among the highest in the region although government measures such as setting price ceilings have reduced some of the disparities between the Philippines and the other ASEAN countries.

This report provides a complete and detailed analysis of the healthcare and pharmaceutical sector for the Philippines. We present in-depth business intelligence in a standard format across countries and regions, providing a balanced mix between analysis and data.

What this report allows you to do:

  • Understand the key elements at play in the healthcare and pharmaceutical sector in the Philippines
  • Access forecasts for growth in the sector
  • View key data on healthcare spending and health insurance in the Philippines
  • Crystallise the forces both driving and restraining this sector in the Philippines
  • Build a complete perspective on sector trade, investment and employment
  • Understand the competitive landscape and who the major players are
  • View M&A activity and major deals
  • Gain an understanding of the regulatory environment for the sector in the Philippines
  • Build a clear picture of trends and issues for sub-sectors (medical institutions, pharmaceuticals manufacturing and distribution channels)
READ MORE
Note: Product cover images may vary from those shown
2 of 4

01 EXECUTIVE SUMMARY

  • Sector in Numbers 2015
  • Sector Overview
  • Sector Snapshot
  • Sector Outlook
  • Subsector Outlook
  • Driving Forces
  • Restraining Forces

02 SECTOR IN FOCUS

  • Focus Point
  • Main Economic Indicators
  • Main Sector Indicators
  • Health Profile
  • Healthcare Expenditure
  • Exchange Rates
  • Consumer Prices
  • FDI
  • Employment
  • Global Positioning – Healthcare

03 COMPETITIVE LANDSCAPE

  • Highlights
  • Top Companies
  • Top M&A Deals
  • M&A Activity, 2014-Q1 2017

04 COMPANIES IN FOCUS

  • Metro Pacific Investments Corp
  • Mercado General Hospital Inc
  • Euro-Med Laboratories Phil Inc
  • United Laboratories Inc (Philippines)
  • Zuellig Pharma Corporation Philippines

05 REGULATORY ENVIRONMENT
Government Policy

06 HEALTHCARE SERVICES

  • Highlights
  • Healthcare Services Demand
  • Healthcare Services Supply
  • Healthcare Maintenance Organisations

07 MEDICAL DEVICES

  • Highlights
  • External Trade in Medical Devices
  • Consumables
  • Diagnostic Imaging
  • Patient Aids

08 PHARMACEUTICALS

  • Highlights
  • External Trade in Pharmaceuticals
  • Prescription Drugs
  • OTC Drugs
  • Traditional and Complementary Medicine

09 RETAIL CHANNELS
Pharmaceutical Distribution

Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • Metro Pacific Investments Corp
  • Mercado General Hospital Inc
  • Euro-Med Laboratories Phil Inc
  • United Laboratories Inc (Philippines)
  • Zuellig Pharma Corporation Philippines
Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown
Adroll
adroll